Target Group Inc.
General ticker "CBDY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.2M (TTM average)
Target Group Inc. does not follow the US Stock Market performance with the rate: -7.8%.
Estimated limits based on current volatility of 12.7%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 49 (-12.5%) as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Pandemic risks, Regulatory and compliance, Banking access issues, Strategic risks and growth management, Agricultural risks
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.00$, 0.00$]
- 2025-12-31 to 2026-12-31 estimated range: [0.00$, 0.00$]
Financial Metrics affecting the CBDY estimates:
- Positive: with PPE of 6.2 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 17.04
- Positive: Operating cash flow per share per price, % of 216.21 > 13.24
- Positive: Inventory ratio change, % of -12.17 <= -0.75
- Negative: Shareholder equity ratio, % of -85.93 <= 18.93
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.08
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -17.89 <= -14.38
Short-term CBDY quotes
Long-term CBDY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $3.72MM | $6.59MM |
| Operating Expenses | $0.45MM | $3.34MM | $5.47MM |
| Operating Income | $-0.45MM | $0.38MM | $1.12MM |
| Non-Operating Income | $-4.07MM | $-0.70MM | $-0.96MM |
| Interest Expense | $1.12MM | $1.46MM | $1.20MM |
| Income(Loss) | $-4.52MM | $-0.32MM | $0.16MM |
| Profit(Loss)* | $-4.52MM | $-0.32MM | $0.16MM |
| Stockholders Equity | $-6.56MM | $-6.97MM | $-6.51MM |
| Inventory | $0.00MM | $1.22MM | $0.88MM |
| Assets | $7.57MM | $8.84MM | $7.57MM |
| Operating Cash Flow | $-1.01MM | $-0.59MM | $2.16MM |
| Capital expenditure | $0.00MM | $0.02MM | $0.07MM |
| Investing Cash Flow | $1.02MM | $0.42MM | $-0.18MM |
| Financing Cash Flow | $0.12MM | $0.67MM | $-0.73MM |
| Earnings Per Share** | $-0.01 | $-0.00 | $0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.